{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T03:00:42Z","timestamp":1773975642658,"version":"3.50.1"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T00:00:00Z","timestamp":1766793600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007660","name":"University of Antwerp","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007660","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011851","name":"Kom op tegen Kanker","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011851","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.biopha.2025.118946","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T23:31:52Z","timestamp":1768433512000},"page":"118946","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Hypoxia induces alterations in the volatile signature of pleural mesothelioma cells"],"prefix":"10.1016","volume":"195","author":[{"given":"Eline","family":"Janssens","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7645-0102","authenticated-orcid":false,"given":"Ellen","family":"Heirwegh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"An","family":"Wouters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lore","family":"Vandermeersch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan P.","family":"Van Meerbeeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe","family":"Walgraeve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elly","family":"Marcq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9500-7461","authenticated-orcid":false,"given":"Kevin","family":"Lamote","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"159","key":"10.1016\/j.biopha.2025.118946_bib1","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0226-2020","article-title":"Update on biology and management of mesothelioma","volume":"30","author":"Asciak","year":"2021","journal-title":"Eur. Respir. Rev."},{"issue":"13","key":"10.1016\/j.biopha.2025.118946_bib2","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJMra1912719","article-title":"Perspectives on the treatment of malignant pleural mesothelioma","volume":"385","author":"Janes","year":"2021","journal-title":"N. Engl. J. Med"},{"issue":"3","key":"10.1016\/j.biopha.2025.118946_bib3","doi-asserted-by":"crossref","first-page":"485","DOI":"10.21037\/jtd.2017.03.27","article-title":"Malignant pleural mesothelioma: key determinants in tailoring the right treatment for the right patient","volume":"9","author":"Wald","year":"2017","journal-title":"J. Thorac. Dis."},{"issue":"10272","key":"10.1016\/j.biopha.2025.118946_bib4","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0140-6736(20)32714-8","article-title":"First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial","volume":"397","author":"Baas","year":"2021","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.biopha.2025.118946_bib5","doi-asserted-by":"crossref","first-page":"924","DOI":"10.21037\/tlcr.2020.03.38","article-title":"Clinical significance of histologic subtyping of malignant pleural mesothelioma","volume":"9","author":"Brcic","year":"2020","journal-title":"Transl. Lung Cancer Res."},{"issue":"4","key":"10.1016\/j.biopha.2025.118946_bib6","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.21037\/jtd-20-2761","article-title":"Epidemiology, diagnosis and treatment of the malignant pleural mesothelioma, a narrative review of literature","volume":"13","author":"Schumann","year":"2021","journal-title":"J. Thorac. Dis."},{"issue":"3","key":"10.1016\/j.biopha.2025.118946_bib7","doi-asserted-by":"crossref","first-page":"259","DOI":"10.21037\/tlcr.2017.05.06","article-title":"Diagnostic and prognostic biomarkers for malignant mesothelioma: an update","volume":"6","author":"Chen","year":"2017","journal-title":"Transl. Lung Cancer Res."},{"issue":"6","key":"10.1016\/j.biopha.2025.118946_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11060831","article-title":"Breath analysis: a systematic review of volatile organic compounds (VOCs) in diagnostic and therapeutic management of pleural mesothelioma","volume":"11","author":"Catino","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.biopha.2025.118946_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/metabo9030052","article-title":"Critical review of volatile organic compound analysis in breath and in vitro cell culture for detection of lung cancer","volume":"9","author":"Jia","year":"2019","journal-title":"Metabolites"},{"issue":"20","key":"10.1016\/j.biopha.2025.118946_bib10","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.2174\/0929867323666160510122913","article-title":"A compendium of volatile organic compounds (VOCs) released by human cell lines","volume":"23","author":"Filipiak","year":"2016","journal-title":"Curr. Med. Chem."},{"issue":"6","key":"10.1016\/j.biopha.2025.118946_bib11","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1007\/s00216-021-03866-8","article-title":"Distinguish oral-source VOCs and control their potential impact on breath biomarkers","volume":"414","author":"Ge","year":"2022","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.biopha.2025.118946_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.851785","article-title":"Headspace volatile organic compound profiling of pleural mesothelioma and lung cancer cell lines as translational bridge for breath research","volume":"12","author":"Janssens","year":"2022","journal-title":"Front. Oncol."},{"issue":"4","key":"10.1016\/j.biopha.2025.118946_bib13","doi-asserted-by":"crossref","DOI":"10.1088\/1752-7163\/abaaff","article-title":"Headspace analysis of mesothelioma cell lines differentiates biphasic and epithelioid sub-types","volume":"14","author":"Little","year":"2020","journal-title":"J. Breath. Res."},{"issue":"33","key":"10.1016\/j.biopha.2025.118946_bib14","doi-asserted-by":"crossref","first-page":"17962","DOI":"10.1021\/acs.analchem.5c01323","article-title":"Investigation of characteristic volatile organic compounds in esophageal cancer organoids by mass spectrometry","volume":"97","author":"Zheng","year":"2025","journal-title":"Anal. Chem."},{"issue":"2","key":"10.1016\/j.biopha.2025.118946_bib15","doi-asserted-by":"crossref","DOI":"10.1088\/1752-7155\/8\/2\/027109","article-title":"Cell culture metabolomics in the diagnosis of lung cancer-the influence of cell culture conditions","volume":"8","author":"Kalluri","year":"2014","journal-title":"J. Breath. Res."},{"key":"10.1016\/j.biopha.2025.118946_bib16","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/981458","article-title":"Current challenges in volatile organic compounds analysis as potential biomarkers of cancer","volume":"2015","author":"Schmidt","year":"2015","journal-title":"J. Biomark."},{"issue":"1035","key":"10.1016\/j.biopha.2025.118946_bib17","doi-asserted-by":"crossref","first-page":"20130676","DOI":"10.1259\/bjr.20130676","article-title":"Defining normoxia, physoxia and hypoxia in tumours-implications for treatment response","volume":"87","author":"McKeown","year":"2014","journal-title":"Br. J. Radio."},{"issue":"1","key":"10.1016\/j.biopha.2025.118946_bib18","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1186\/s12885-018-4720-z","article-title":"Hypoxia promotes acquisition of aggressive phenotypes in human malignant mesothelioma","volume":"18","author":"Kim","year":"2018","journal-title":"BMC Cancer"},{"issue":"5","key":"10.1016\/j.biopha.2025.118946_bib19","doi-asserted-by":"crossref","first-page":"5131","DOI":"10.1021\/acsomega.7b02035","article-title":"Detection of lung cancer: concomitant volatile organic compounds and metabolomic profiling of six cancer cell lines of different histological origins","volume":"3","author":"Jia","year":"2018","journal-title":"ACS Omega"},{"issue":"1","key":"10.1016\/j.biopha.2025.118946_bib20","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2021-002337","article-title":"Human serum metabolomic analysis reveals progression for high blood pressure in type 2 diabetes mellitus","volume":"9","author":"Zhang","year":"2021","journal-title":"BMJ Open Diabetes Res. Care"},{"issue":"8","key":"10.1016\/j.biopha.2025.118946_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/foods10081829","article-title":"Authentication and chemometric discrimination of six greek PDO table olive varieties through morphological characteristics of their stones","volume":"10","author":"Agriopoulou","year":"2021","journal-title":"Foods"},{"issue":"2","key":"10.1016\/j.biopha.2025.118946_bib22","doi-asserted-by":"crossref","DOI":"10.1088\/1752-7155\/8\/2\/027105","article-title":"Current breathomics--a review on data pre-processing techniques and machine learning in metabolomics breath analysis","volume":"8","author":"Smolinska","year":"2014","journal-title":"J. Breath. Res."},{"issue":"7-8","key":"10.1016\/j.biopha.2025.118946_bib23","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1007\/s00216-010-4238-y","article-title":"Chemical characterization of exhaled breath to differentiate between patients with malignant plueral mesothelioma from subjects with similar professional asbestos exposure","volume":"398","author":"de Gennaro","year":"2010","journal-title":"Anal. Bioanal. Chem."},{"issue":"53","key":"10.1016\/j.biopha.2025.118946_bib24","doi-asserted-by":"crossref","first-page":"91593","DOI":"10.18632\/oncotarget.21335","article-title":"Breath analysis by gas chromatography-mass spectrometry and electronic nose to screen for pleural mesothelioma: a cross-sectional case-control study","volume":"8","author":"Lamote","year":"2017","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.biopha.2025.118946_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12051262","article-title":"Breath analysis for early detection of malignant pleural mesothelioma: volatile organic compounds (VOCs) determination and possible biochemical pathways","volume":"12","author":"Di Gilio","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.biopha.2025.118946_bib26","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s10014-013-0170-0","article-title":"Hypoxia upregulates aldehyde dehydrogenase isoform 1 (ALDH1) expression and induces functional stem cell characteristics in human glioblastoma cells","volume":"31","author":"Soehngen","year":"2014","journal-title":"Brain Tumor Pathol."},{"issue":"3","key":"10.1016\/j.biopha.2025.118946_bib27","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.3892\/ol.2017.6613","article-title":"Interleukin-6 identified as an important factor in hypoxia- and aldehyde dehydrogenase-based gefitinib adaptive resistance in non-small cell lung cancer cells","volume":"14","author":"An","year":"2017","journal-title":"Oncol. Lett."},{"issue":"9","key":"10.1016\/j.biopha.2025.118946_bib28","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.4161\/cc.10.9.15486","article-title":"Aldehyde dehydrogenase: its role as a cancer stem cell marker comes down to the specific isoform","volume":"10","author":"Marcato","year":"2011","journal-title":"Cell Cycle"},{"issue":"13","key":"10.1016\/j.biopha.2025.118946_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27134012","article-title":"Volatilomic signatures of AGS and SNU-1 gastric cancer cell lines","volume":"27","author":"Slefarska-Wolak","year":"2022","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.biopha.2025.118946_bib30","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/cbf.3612","article-title":"Hypoxia as a modulator of cytochromes P450: overexpression of the cytochromes CYP2S1 and CYP24A1 in human liver cancer cells in hypoxia","volume":"39","author":"Cabrera-Cano","year":"2021","journal-title":"Cell Biochem. Funct."},{"issue":"6","key":"10.1016\/j.biopha.2025.118946_bib31","first-page":"2798","article-title":"Upregulation of CYP1B1 by hypoxia is mediated by ERalpha activation in breast cancer cells","volume":"12","author":"Min","year":"2022","journal-title":"Am. J. Cancer Res."},{"issue":"1","key":"10.1016\/j.biopha.2025.118946_bib32","first-page":"178","article-title":"Hypoxia increases chemoresistance in human medulloblastoma DAOY cells via hypoxia\u2011inducible factor 1alpha\u2011mediated downregulation of the CYP2B6, CYP3A4 and CYP3A5 enzymes and inhibition of cell proliferation","volume":"41","author":"Valencia-Cervantes","year":"2019","journal-title":"Oncol. Rep."},{"issue":"11","key":"10.1016\/j.biopha.2025.118946_bib33","doi-asserted-by":"crossref","first-page":"5949","DOI":"10.1021\/cr300174a","article-title":"Volatile organic compounds of lung cancer and possible biochemical pathways","volume":"112","author":"Hakim","year":"2012","journal-title":"Chem. Rev."},{"issue":"2","key":"10.1016\/j.biopha.2025.118946_bib34","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/toxsci\/kfn244","article-title":"Mechanism of ethylbenzene-induced mouse-specific lung tumor: metabolism of ethylbenzene by rat, mouse, and human liver and lung microsomes","volume":"107","author":"Saghir","year":"2009","journal-title":"Toxicol. Sci."},{"issue":"12","key":"10.1016\/j.biopha.2025.118946_bib35","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1177\/0748233715602834","article-title":"Roles of oxidative stress, apoptosis, and heme oxygenase-1 in ethylbenzene-induced renal toxicity in NRK-52E cells","volume":"32","author":"Zhang","year":"2016","journal-title":"Toxicol. Ind. Health"},{"issue":"1","key":"10.1016\/j.biopha.2025.118946_bib36","doi-asserted-by":"crossref","DOI":"10.1093\/biomethods\/bpz014","article-title":"Digging deeper into volatile organic compounds associated with cancer","volume":"4","author":"Janfaza","year":"2019","journal-title":"Biol. Methods Protoc."},{"issue":"1","key":"10.1016\/j.biopha.2025.118946_bib37","first-page":"419","article-title":"Release of volatile organic compounds from the lung cancer cell line NCI-H2087 in vitro","volume":"29","author":"Sponring","year":"2009","journal-title":"Anticancer Res."},{"issue":"21","key":"10.1016\/j.biopha.2025.118946_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222112071","article-title":"Insights into intra-tumoral heterogeneity: transcriptional profiling of chemoresistant MPM cell subpopulations reveals involvement of NFkB and DNA repair pathways and contributes a prognostic signature","volume":"22","author":"Cioce","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.biopha.2025.118946_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24076689","article-title":"A Selective ALDH1A3 inhibitor impairs mesothelioma 3-D multicellular spheroid growth and neutrophil recruitment","volume":"24","author":"Boumya","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2025.118946_bib40","doi-asserted-by":"crossref","first-page":"121","DOI":"10.32471\/exp-oncology.2312-8852.vol-44-no-2.18045","article-title":"Chemoresistance related to hypoxia adaptation in mesothelioma cells from tumor spheroids","volume":"44","author":"Endoh","year":"2022","journal-title":"Exp. Oncol."},{"issue":"38","key":"10.1016\/j.biopha.2025.118946_bib41","doi-asserted-by":"crossref","first-page":"25115","DOI":"10.18632\/oncotarget.25344","article-title":"ADH1B promotes mesothelial clearance and ovarian cancer infiltration","volume":"9","author":"Gharpure","year":"2018","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.biopha.2025.118946_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/cells8020172","article-title":"Chronic hypoxia enhances beta-oxidation-dependent electron transport via electron transferring flavoproteins","volume":"8","author":"Fuhrmann","year":"2019","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.biopha.2025.118946_bib43","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.cmet.2023.02.007","article-title":"Organ-specific fuel rewiring in acute and chronic hypoxia redistributes glucose and fatty acid metabolism","volume":"35","author":"Midha","year":"2023","journal-title":"Cell Metab."},{"issue":"2","key":"10.1016\/j.biopha.2025.118946_bib44","doi-asserted-by":"crossref","first-page":"198","DOI":"10.4103\/mgr.MEDGASRES-D-24-00101","article-title":"Non-invasive detection of early-stage lung cancer through exhaled breath volatile organic compound analysis","volume":"15","author":"Binson","year":"2025","journal-title":"Med. Gas. Res"},{"key":"10.1016\/j.biopha.2025.118946_bib45","article-title":"Review of cancer cell volatile organic compounds: their metabolism and evolution","volume":"11","author":"Furuhashi","year":"2024","journal-title":"Front. Mol. Biosci."},{"issue":"9","key":"10.1016\/j.biopha.2025.118946_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1005758","article-title":"A metabolic core model elucidates how enhanced utilization of glucose and glutamine, with enhanced glutamine-dependent lactate production, promotes cancer cell growth: the WarburQ effect","volume":"13","author":"Damiani","year":"2017","journal-title":"PLoS Comput. Biol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118946_bib47","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11306-020-1635-x","article-title":"Extracellular volatilomic alterations induced by hypoxia in breast cancer cells","volume":"16","author":"Taware","year":"2020","journal-title":"Metabolomics"},{"issue":"5","key":"10.1016\/j.biopha.2025.118946_bib48","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.nano.2011.10.001","article-title":"Classification of lung cancer histology by gold nanoparticle sensors","volume":"8","author":"Barash","year":"2012","journal-title":"Nanomedicine"},{"issue":"5","key":"10.1016\/j.biopha.2025.118946_bib49","first-page":"402","article-title":"Mesothelioma: scientific clues for prevention, diagnosis, and therapy","volume":"69","author":"Carbone","year":"2019","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.biopha.2025.118946_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2024.107542","article-title":"Establishing mesothelioma patient-derived organoid models from malignant pleural effusions","volume":"191","author":"Hocking","year":"2024","journal-title":"Lung Cancer"},{"key":"10.1016\/j.biopha.2025.118946_bib51","article-title":"3-Dimensional mesothelioma spheroids provide closer to natural pathophysiological tumor microenvironment for drug response studies","volume":"12","author":"Shi","year":"2022","journal-title":"Front. Oncol."},{"issue":"52","key":"10.1016\/j.biopha.2025.118946_bib52","doi-asserted-by":"crossref","first-page":"20398","DOI":"10.1021\/acs.analchem.4c03894","article-title":"Developing multiple media approach to investigate reproducible characteristic VOCs of lung cancer cells","volume":"96","author":"Zhou","year":"2024","journal-title":"Anal. Chem."},{"key":"10.1016\/j.biopha.2025.118946_bib53","article-title":"The volatilomic footprints of human HGC-27 and CLS-145 gastric cancer cell lines","volume":"7","author":"Leiherer","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.biopha.2025.118946_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.989523","article-title":"Hypoxia-driven metabolic reprogramming of adipocytes fuels cancer cell proliferation","volume":"13","author":"Aird","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225011400?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225011400?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T02:04:56Z","timestamp":1773972296000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225011400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":54,"alternative-id":["S0753332225011400"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118946","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypoxia induces alterations in the volatile signature of pleural mesothelioma cells","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118946","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118946"}}